文献速递儿科与产科急症

不孕治疗受孕的足月单胎妊娠的孕龄与出生结局

Gestational Age and Birth Outcomes in Term Singleton Pregnancies Conceived With Infertility Treatment.
PubMed 文献 · JAMA Netw Open · 2023-08-01
一句话结论不孕治疗受孕的足月单胎妊娠,39周分娩时围产风险最低(风险479 vs 后续周599/10000活产)。

这项基于美国国家卫生统计中心2014年1月1日至2018年12月31日出生与死亡数据的队列研究,纳入178448例不孕治疗受孕的足月单胎妊娠,比较37-42周各孕周当周分娩风险与期待至下一周分娩的风险(当周死胎率/10000持续妊娠+下一周新生儿并发症及婴儿死亡率/10000分娩)。结果显示,下一周分娩风险在37周(628 vs 1005/10000活产)和38周(483 vs 625/10000活产)低于当周,在39周显著超过当周(599 vs 479/10000活产),40周(639 vs 594/10000活产)和41周(701 vs 633/10000活产)无显著差异。作者认为,不孕治疗受孕的妊娠在39周分娩围产风险最低。

要点

  • 不孕治疗受孕足月单胎妊娠,39周当周分娩风险为479/10000活产,期待至下一周为599/10000活产,后者显著更高。
  • 37周当周分娩风险1005/10000活产,期待至下一周为628/10000活产,期待至下一周风险更低。
  • 38周当周分娩风险625/10000活产,期待至下一周为483/10000活产,期待至下一周风险更低。
  • 40周当周分娩风险594/10000活产 vs 期待至下一周639/10000活产,41周633 vs 701/10000活产,均无显著差异。

适用人群与场景

  • 美国2014年1月1日至2018年12月31日出生与死亡数据中,不孕治疗受孕、37-42周分娩的单胎妊娠。
  • 排除<37周或≥43周分娩、不孕治疗史未知、先天性畸形、孕前糖尿病、孕前高血压、妊娠期高血压和子痫前期者。

研究设计与关键结果

  • 研究类型:队列研究,利用美国国家卫生统计中心2014年1月1日至2018年12月31日出生与死亡数据;样本量178448例不孕治疗受孕的足月单胎妊娠;母亲平均(SD)年龄34.2(5.2)岁,平均(SD)孕龄39.2(1.2)周,130786例(73.5%)为非西班牙裔白人。
  • 主要结局为分娩最佳时机:比较某孕周当周分娩风险(新生儿并发症及婴儿死亡率)与期待至下一周分娩的风险(当周死胎率/10000持续妊娠+下一周新生儿并发症及婴儿死亡率/10000分娩)。
  • 37周当周分娩风险1005(95%CI 961-1050)/10000活产 vs 期待至下一周628(95%CI 601-656)/10000活产,期待至下一周更低。
  • 38周当周分娩风险625(95%CI 598-652)/10000活产 vs 期待至下一周483(95%CI 467-500)/10000活产,期待至下一周更低。
  • 39周当周分娩风险479(95%CI 463-495)/10000活产 vs 期待至下一周599(95%CI 576-622)/10000活产,期待至下一周显著更高。
  • 40周当周分娩风险594(95%CI 572-617)/10000活产 vs 期待至下一周639(95%CI 605-675)/10000活产,无显著差异。
  • 41周当周分娩风险633(95%CI 599-669)/10000活产 vs 期待至下一周701(95%CI 628-781)/10000活产,无显著差异。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在不孕治疗受孕的妊娠中,与期待至下一周相比,39周分娩的围产风险最低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Despite the increased perinatal risks associated with pregnancies conceived with infertility treatment, there are no recommendations for timing of delivery among this at-risk population.

OBJECTIVE: To identify the gestational age at which the ongoing risks of stillbirth are optimally balanced with the risks of neonatal comorbidities and infant deaths in term singleton pregnancies conceived with infertility treatment.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used birth and death data from January 1, 2014, to December 31, 2018, in the US obtained from the National Center for Health Statistics. Singleton pregnancies conceived with infertility treatment delivered at term (37-42 weeks' gestation) were eligible for inclusion. The exclusion criteria were deliveries at less than 37 weeks' or at least 43 weeks' gestation and pregnancies with unknown history of infertility treatment, congenital anomalies, pregestational diabetes, pregestational hypertension, gestational hypertension, and preeclampsia. Data were analyzed from July 22, 2022, to June 24, 2023.

EXPOSURE: Gestational age at delivery between 37 and 42 weeks.

MAIN OUTCOMES AND MEASURES: The primary outcome was optimal timing of delivery. To ascertain this timing, the risk of delivery (rate of neonatal morbidity and infant death) at a given gestational week was compared with the risk of delivery in the subsequent week of gestation for an additional week (rate of stillbirth during the given week per 10 000 ongoing pregnancies plus rate of neonatal morbidity and infant death in the subsequent week of gestation per 10 000 deliveries). The rates of stillbirth, neonatal morbidity, and infant death (within 1 year of life) were compared at each week. Neonatal morbidity included an Apgar score of 3 or lower at 5 minutes, requirement of ventilation for 6 hours or more, neonatal intensive care unit admission, and seizures.

RESULTS: Of the 178 448 singleton term pregnancies conceived with infertility treatment (maternal mean [SD] age, 34.2 [5.2] years; mean [SD] gestational age, 39.2 [1.2] weeks; 130 786 [73.5%] were non-Hispanic White patients). The risk of delivery in the subsequent week of gestation was lower than the risk of delivery at both 37 weeks (628 [95% CI, 601-656] vs 1005 [95% CI, 961-1050] per 10 000 live births) and 38 weeks (483 [95% CI, 467-500 vs 625 [95% CI, 598-652] per 10 000 live births). The risks of delivery in subsequent week of gestation significantly exceeded the risk of delivery at 39 weeks (599 [95% CI, 576-622] vs 479 [95% CI, 463-495] per 10 000 live births) and were not significant at 40 weeks (639 [95% CI, 605-675] vs 594 [95% CI, 572-617] per 10 000 live births) and 41 weeks (701 [95% CI, 628-781] vs 633 [95% CI, 599-669] per 10 000 live births).

CONCLUSIONS AND RELEVANCE: Results of this study suggest that, in pregnancies conceived with infertility treatment, delivery at 39 weeks provided the lowest perinatal risk when comparing risk of delivery at this week of gestation vs the subsequent week of gestation.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Hamilton I, Martin N, Liu J, et al. Gestational Age and Birth Outcomes in Term Singleton Pregnancies Conceived With Infertility Treatment. JAMA Netw Open. 2023. PMID: 37566418. doi:10.1001/jamanetworkopen.2023.28335

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。